- Home
- ADTN vs EIKN Comparison
ADTN vs EIKN Comparison
Compare ADTN & EIKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ADTN | EIKN |
|---|---|---|
| Founded | 1985 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 559.8M | 631.0M |
| IPO Year | 1996 | 2026 |
Fundamental Metrics
Financial Performance| Metric | ADTN | EIKN |
|---|---|---|
| Price | $7.04 | $7.25 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 6 |
| Target Price | $14.67 | ★ $24.60 |
| AVG Volume (30 Days) | ★ 1.5M | 607.0K |
| Earning Date | 11-03-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 90.83 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,083,807,000.00 | N/A |
| Revenue This Year | $5.74 | N/A |
| Revenue Next Year | $7.88 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 17.46 | N/A |
| 52 Week Low | $6.73 | $7.02 |
| 52 Week High | $19.98 | $16.50 |
Technical Indicators
Market Signals| Indicator | ADTN | EIKN |
|---|---|---|
| Relative Strength Index (RSI) | 42.99 | 32.53 |
| Support Level | $6.85 | $7.02 |
| Resistance Level | $7.34 | $10.20 |
| Average True Range (ATR) | 0.31 | 0.54 |
| MACD | 0.09 | 0.01 |
| Stochastic Oscillator | 25.45 | 12.73 |
Price Performance
Historical ComparisonAbout ADTN ADTRAN Holdings Inc.
Adtran Holdings Inc is a provider of networking and communications platforms, software, and services focused on the broadband access market. It operates under two reportable segments: Network Solutions segment, which includes hardware and software products that enable a digital future that supports the company's Subscriber, Access & Aggregation, and Optical Networking Solutions; and Services & Support segment, which includes network design, implementation, maintenance and cloud-hosted services supporting the company's Subscriber, Access & Aggregation, and Optical Networking Solutions. It generates the majority of its revenue from the Network Solutions segment.
About EIKN Eikon Therapeutics Inc. Common Stock
Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.